This sex-dependent activation of IFN-α by TLR7 may explain the higher prevalence of SLE in females and the reported decrease in therapeutic efficacy of synthetic TLR7 ligands in males [173]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.